Life Science Leader Opinion Piece By Megan Duckering, Senior Consultant and Ashwin Singhania, Partner - Guidehouse
Hospitals represent a critical access point for many therapeutics. Whether a therapeutic is indicated for use exclusively in a hospital or in both inpatient and outpatient settings, hospitals are key points of drug initiation or switching. To gain access to this channel, pharma companies must understand the needs and differences of hospital systems.
Today, hospital or system-wide pharmaceutical and therapeutic (P&T) committees determine which products to make available on the hospital.